Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 28 min ago
Peer-reviewedCC BY-NC-NDCancer science

Dioscin Promotes Ferroptosis in Cervical Cancer Cells via the TIGAR-ROS Axis.

  • Yameng Liu1,2
  • Hongli Xi1,2
  • Shaoju Min1,2
  • Hanlin Yang1,2
  • Li Hou1,2
  • Hailong Zhang1,2
  • Yujie Tan1,2
  1. 1Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  2. 2School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, China.
Read full textPDFDOICite

Abstract

Cervical cancer seriously threatens women's life and health, highlighting the urgent need for targeted therapies. TP53-induced glycolysis regulatory phosphatase (TIGAR), upregulated in cervical cancer and regulated by HPV E6, may be involved in cervical cancer progression, making its inhibition a potential therapeutic strategy. This study aims to investigate the role and mechanism of TIGAR in cervical cancer ferroptosis resistance and identify a TIGAR-targeting drug to suppress cervical cancer advancement. Through RNA-seq, transmission electron microscopy, and western blotting, we found that TIGAR knockdown significantly promoted ferroptosis by increasing intracellular lipid reactive oxygen species (ROS) levels. Furthermore, through molecular docking, CETSA, and SPR analysis, we identified Dioscin as a compound that binds to TIGAR. Dioscin treatment effectively inhibited cervical tumors via TIGAR both in vitro and in vivo. Mechanistically, Dioscin interacted with TIGAR and promoted ferroptosis, at least in part, through the TIGAR-ROS axis. Collectively, these findings indicate that TIGAR suppresses ferroptosis via lipid ROS reduction, while Dioscin counteracts this process, at least in part, through the TIGAR-ROS axis. Thus, Dioscin holds promise as a potential targeted therapeutic agent for cervical cancer.

Related

  1. Calycosin synergistically promotes ferroptosis in cervical cancer cells by inducing epithelial-mesenchymal transition
    Lei Zhang, Qiuyi Shen, Jingyi Zhu +3
    Oncology LettersPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  2. Tamarixetin promotes ferroptosis-associated redox stress and compensatory activation of nuclear factor erythroid 2-related factor 2 in hepatoma cells
    Dong-Hee Han, Min Kyoung Shin, Sumin Lee +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  3. Targeting REV7 confers cervical cancer cell radiosensitivity and ferroptosis by negatively regulating SFXN1
    Xue Huang, Yang Feng, Yuxing Yang +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  4. SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis
    Jianfeng Hu, Yangmin Wang, Yonghui Du +4
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. MSRB3 promotes gastric cancer progression and immunotherapy resistance by stabilizing GPX4 to inhibit ferroptosis
    Jianqin Lai, Taiwei Mo, Jinxuan Su +9
    Translational oncologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{liu2026dioscin,
  title = {{Dioscin Promotes Ferroptosis in Cervical Cancer Cells via the TIGAR-ROS Axis.}},
  author = {Yameng Liu and Hongli Xi and Shaoju Min and Hanlin Yang and Li Hou and Hailong Zhang and Yujie Tan},
  journal = {Cancer science},
  year = {2026},
  month = oct,
  doi = {10.1111/cas.70560},
  url = {https://europepmc.org/article/MED/42925104},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Dioscin Promotes Ferroptosis in Cervical Cancer Cells via the TIGAR-ROS Axis.
AU  - Yameng Liu
AU  - Hongli Xi
AU  - Shaoju Min
AU  - Hanlin Yang
AU  - Li Hou
AU  - Hailong Zhang
AU  - Yujie Tan
PY  - 2026
DA  - 2026/10/23
JO  - Cancer science
DO  - 10.1111/cas.70560
UR  - https://europepmc.org/article/MED/42925104
AB  - Cervical cancer seriously threatens women's life and health, highlighting the urgent need for targeted therapies. TP53-induced glycolysis regulatory phosphatase (TIGAR), upregulated in cervical cancer and regulated by HPV E6, may be involved in cervical cancer progression, making its inhibition a potential therapeutic strategy. This study aims to investigate the role and mechanism of TIGAR in cervical cancer ferroptosis resistance and identify a TIGAR-targeting drug to suppress cervical cancer advancement. Through RNA-seq, transmission electron microscopy, and western blotting, we found that TIGAR knockdown significantly promoted ferroptosis by increasing intracellular lipid reactive oxygen species (ROS) levels. Furthermore, through molecular docking, CETSA, and SPR analysis, we identified Dioscin as a compound that binds to TIGAR. Dioscin treatment effectively inhibited cervical tumors via TIGAR both in vitro and in vivo. Mechanistically, Dioscin interacted with TIGAR and promoted ferroptosis, at least in part, through the TIGAR-ROS axis. Collectively, these findings indicate that TIGAR suppresses ferroptosis via lipid ROS reduction, while Dioscin counteracts this process, at least in part, through the TIGAR-ROS axis. Thus, Dioscin holds promise as a potential targeted therapeutic agent for cervical cancer.
SN  - 1347-9032
SN  - 1349-7006
ER  -